Related content

ERK Phosphorylation Is Not Increased in Papillary Thyroid Carcinomas with BRAF V600E Mutation Compared to That of Corresponding Normal Thyroid Tissues

By Kim Sun Wook  

Endocrine Research, Vol. 38, Iss. 2, 2012-05 ,pp. : 89-97

Informa Healthcare

Access to resources Recommend Favorite

Presence of the BRAF V600E point mutation in morphologically benign appearing thyroid inclusions of cervical lymph nodes

By Mojica Wilfrido   Khoury Thaer  

Endocrine Pathology, Vol. 17, Iss. 2, 2006-06 ,pp. : 183-189

Humana Press, Inc

Access to resources Recommend Favorite

BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?

By Puxeddu Efisio   Filetti Sebastiano  

Endocrine, Vol. 45, Iss. 3, 2014-04 ,pp. : 341-343

Springer Publishing Company

Access to resources Recommend Favorite

BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis

By Sargent Rachel   LiVolsi Virginia   Murphy Justin   Mantha Geeta   Hunt Jennifer  

Endocrine Pathology, Vol. 17, Iss. 3, 2006-09 ,pp. : 235-241

Humana Press, Inc

Access to resources Recommend Favorite

BRAF ^V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay

By Guerra Anna   Stasi Vincenza   Zeppa Pio   Faggiano Antongiulio   Marotta Vincenzo   Vitale Mario  

Endocrine, Vol. 45, Iss. 2, 2014-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite